---
title: "JENKEM: Subsidiary's new product obtains medical device registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237535722.md"
description: "On April 25th, JENKEM announced that its wholly-owned subsidiary Tianjin JENKEM Technology Co., Ltd. has obtained the Medical Device Registration Certificate issued by the National Medical Products Administration of the People's Republic of China for injectable cross-linked sodium hyaluronate gel. This product is suitable for medium to deep layer injections in the dermal tissue of the nasolabial fold area to correct moderate to severe nasolabial fold wrinkles"
datetime: "2025-04-25T08:48:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237535722.md)
  - [en](https://longbridge.com/en/news/237535722.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237535722.md)
---

# JENKEM: Subsidiary's new product obtains medical device registration certificate

On April 25th, JENKEM announced that its wholly-owned subsidiary Tianjin JENKEM Technology Co., Ltd. has obtained the Medical Device Registration Certificate issued by the National Medical Products Administration of the People's Republic of China for its injectable cross-linked sodium hyaluronate gel. This product is suitable for medium to deep dermal tissue injections in the nasolabial fold area of the face to correct moderate to severe nasolabial fold wrinkles

### Related Stocks

- [688356.CN](https://longbridge.com/en/quote/688356.CN.md)

## Related News & Research

- [Iranian parliament votes to further criminalise interviews with 'hostile media'](https://longbridge.com/en/news/296022899.md)
- [10:52 ETCosmetic Physician Partners Ranks in Top 10% of 2026 Inc. 5000 List of Fastest-Growing Private Companies](https://longbridge.com/en/news/295681753.md)
- [Faeth Therapeutics wins FDA fast-track status for PIKTOR-paclitaxel in advanced endometrial cancer](https://longbridge.com/en/news/296098405.md)
- [Faeth Therapeutics wins FDA fast-track status for PIKTOR plus paclitaxel in biomarker-selected advanced endometrial cancer](https://longbridge.com/en/news/296098241.md)
- [BRE: Rocha da Rocha delivers world-class rare earth economics with ultra-high grades and lowest Western costs](https://longbridge.com/en/news/295851711.md)